- Corporate Officers - R
- Richman Eric I
Insider Trading History of Richman Eric I
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Richman Eric I since 2010.
This trader's CIK number is 1313876.
At the time of last reporting, Richman Eric I was the Officer of Gain Therapeutics, Inc.. (stock ticker symbol GANX).
Also see all insider trading activities at Gain Therapeutics, Inc..
Note that in the past
RICHMAN ERIC I also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Gain Therapeutics, Inc. (GANX) by Richman Eric I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | GANX | 17,000 | $20,740 | 0 | $0 | 0 | $0 |
| 2023 | GANX | 0 | $0 | 0 | $0 | 54,900 | $0 |
| 2022 | GANX | 15,738 | $43,437 | 0 | $0 | 0 | $0 |
| 2021 | GANX | 0 | $0 | 0 | $0 | 4,922 | $38,716 |
Yearly summary of insider trading at Altimmune, Inc. (PIP) by Richman Eric I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | PIP | 0 | $0 | 341,121 | $750,465 | 1,062,354 | $1,687,796 |
| 2011 | PIP | 10,000 | $15,029 | 0 | $0 | 0 | $0 |
| 2010 | PIP | 10,000 | $15,770 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Adma Biologics, Inc. (ADMA) by Richman Eric I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ADMA | 5,230 | $24,999 | 0 | $0 | 0 | $0 |
| 2017 | ADMA | 25,000 | $53,750 | 0 | $0 | 2,800 | $7,504 |
| 2015 | ADMA | 3,500 | $27,510 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neubase Therapeutics, Inc. (NBSE) by Richman Eric I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | NBSE | 3,880 | $6,352 | 0 | $0 | 0 | $0 |
| 2020 | NBSE | 10,833 | $64,998 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Richman Eric I:
1. Gain Therapeutics, Inc. (GANX)
2. Altimmune, Inc. (PIP)
3. Adma Biologics, Inc. (ADMA)
4. Neubase Therapeutics, Inc. (NBSE)
Table 1. Insider trading of Gain Therapeutics, Inc. (GANX) by Richman Eric I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-07-01 | GANX | Buy | 17,000 | 1.22 | 20,740 |
| 2023-09-20 | GANX | Option Ex | 54,900 | .00 | 0 |
| 2022-05-25 | GANX | Buy | 2,482 | 2.58 | 6,403 |
| 2022-05-19 | GANX | Buy | 4,000 | 2.71 | 10,840 |
| 2022-05-20 | GANX | Buy | 9,256 | 2.83 | 26,194 |
| 2021-08-16 | GANX | Option Ex | 4,922 | 7.87 | 38,716 |
Table 2. Insider trading of Altimmune, Inc. (PIP) by Richman Eric I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-11-22 | PIP | Option Ex | 483,733 | 1.86 | 902,162 |
| 2016-09-28 | PIP | Option Ex | 237,500 | 1.39 | 330,837 |
| 2016-04-13 | PIP | Sale | 329,354 | 2.20 | 724,578 |
| 2016-04-13 | PIP | Option Ex | 329,354 | 1.32 | 434,088 |
| 2016-04-08 | PIP | Sale | 6,400 | 2.20 | 14,080 |
| 2016-04-07 | PIP | Sale | 5,367 | 2.20 | 11,807 |
| 2016-04-08 | PIP | Option Ex | 6,400 | 1.76 | 11,264 |
| 2016-04-07 | PIP | Option Ex | 5,367 | 1.76 | 9,445 |
| 2011-11-10 | PIP | Buy | 10,000 | 1.50 | 15,029 |
| 2010-06-17 | PIP | Buy | 10,000 | 1.58 | 15,770 |
Table 3. Insider trading of Adma Biologics, Inc. (ADMA) by Richman Eric I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-06-08 | ADMA | Buy | 5,230 | 4.78 | 24,999 |
| 2017-11-09 | ADMA | Buy | 25,000 | 2.15 | 53,750 |
| 2017-07-13 | ADMA | Option Ex | 2,800 | 2.68 | 7,504 |
| 2015-03-13 | ADMA | Buy | 3,500 | 7.86 | 27,510 |
Table 4. Insider trading of Neubase Therapeutics, Inc. (NBSE) by Richman Eric I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-01 | NBSE | Buy | 1,580 | 1.58 | 2,496 |
| 2022-03-04 | NBSE | Buy | 1,000 | 1.62 | 1,620 |
| 2022-03-03 | NBSE | Buy | 1,300 | 1.72 | 2,236 |
| 2020-04-30 | NBSE | Buy | 10,833 | 6.00 | 64,998 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Richman Eric I
(Officer of Gain Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.